CITADEL ADVISORS LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Terns Pharmaceuticals, Inc. (TERN)

Filing Manager
CITADEL ADVISORS LLC
Reporting Manager
Kenneth Griffin
Security
Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (the "Shares")
Symbol
TERN
Shares outstanding
84.5M shares
Disclosed Ownership
3.47M shares
Ownership
4.1%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 06:25 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Citadel Advisors LLC 3.9% 3.27M 0 3.27M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Advisors Holdings LP 3.9% 3.27M 0 3.27M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel GP LLC 3.9% 3.27M 0 3.27M /s/ Seth Levy Seth Levy, Authorized Signatory
Citadel Securities LLC 0.2% 198K 0 198K /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities Group LP 0.2% 198K 0 198K /s/ Guy Miller Guy Miller, Authorized Signatory
Citadel Securities GP LLC 0.2% 198K 0 198K /s/ Guy Miller Guy Miller, Authorized Signatory
Kenneth Griffin 4.1% 3.47M 0 3.47M /s/ Seth Levy Seth Levy, attorney-in-fact*